Printer Friendly

Articles from M2 Pharma (March 28, 2019)

1-20 out of 20 article(s)
Title Author Type Words
AstraZeneca's Forxiga receives approval in Japan for type-1 diabetes. 349
Can-Fite Releases Mixed Phase II Advanced Liver Cancer Top-Line Results for its Orphan/Fast Track Drug Namodenoson. 796
Casma Therapeutics Establishes Scientific Advisory Board with Appointments of Autophagy and Neuroscience Researchers. 565
Destiny Pharma selects MedPharm as expert partner to produce topical formulations of XF-platform compounds. 146
Enamine Extends Multi-Year Drug Discovery Collaboration with Lundbeck. 239
Genmab's partner submits Type II variation application to EMA for Daratumumab. 331
Ichor Medical Systems Forges Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform. 342
Initial Phase 2 Data from an IMV Clinical Study Continues to Demonstrate DPX-Survivac's Prior Trend as a Potential Monotherapy Treatment for Advanced Ovarian Cancer. Clinical report 435
Innovative Neurological Devices awarded the US FDA's clearance for the Cervella CES device for treating anxiety, insomnia and depression. 225
Japanese authorities approve AbbVie's SKYRIZI. 179
Leo Pharma Standardises on Veeva Development Cloud to Speed Drug Development. 352
MiRus passes US FDA's 510(k) clearance for first MoRe implant with new superalloy. 190
MoleSafe USA hires Mark Kaufmann, MD as CMO. 149
Phio Pharmaceuticals narrows net loss to USD7.4m in 2018. Financial report 266
Synspira Therapeutics names new president, CEO and director. 144
The US FDA grants approval for new oral testosterone capsule for treating certain forms of hypogonadism in men. 221
Transgene and BioInvent Extend their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors. 433
Upsher-Smith unveils generic Prozac (fluoxetine) Tablets in the US antidepressant market. 120
US Food and Drug Administration approves Novartis' Mayzent. 169
Vect-Horus Enters Collaboration and License Agreement with Ono Pharmaceutical. 248

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters